Faculty Opinions recommendation of Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.
2015 ◽
Vol 3
(7)
◽
pp. 524-533
◽
2019 ◽
Vol 7
(11)
◽
pp. 834-844
◽
2020 ◽
Vol 39
(2)
◽
pp. 215-220
◽